Jean-Marc Bellemin
Director of Finance/CFO en IOVANCE BIOTHERAPEUTICS, INC. .
Fortuna: 868 096 $ al 31/03/2024
Cargos activos de Jean-Marc Bellemin
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Comptroller/Controller/Auditor | 11/03/2021 | - |
Director of Finance/CFO | 14/12/2020 | - | |
Treasurer | 14/12/2020 | - |
Historial de carrera de Jean-Marc Bellemin
Antiguos cargos conocidos de Jean-Marc Bellemin.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GRITSTONE BIO, INC. | Director of Finance/CFO | 01/01/2018 | 11/12/2020 |
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Corporate Officer/Principal | 01/01/2008 | 01/12/2017 |
Formación de Jean-Marc Bellemin.
Université Paris Dauphine-PSL | Undergraduate Degree |
ESSEC Business School | Masters Business Admin |
Université Paris II Panthéon Assas | Graduate Degree |
Estadísticas
Internacional
Francia | 4 |
Estados Unidos | 4 |
Operativa
Director of Finance/CFO | 2 |
Corporate Officer/Principal | 1 |
Undergraduate Degree | 1 |
Sectorial
Consumer Services | 4 |
Health Technology | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
IOVANCE BIOTHERAPEUTICS, INC. | Health Technology |
GRITSTONE BIO, INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Actelion Pharmaceuticals US, Inc.
Actelion Pharmaceuticals US, Inc. Pharmaceuticals: MajorHealth Technology Part of Johnson & Johnson, Actelion Pharmaceuticals US, Inc. is a private company that manufactures, distributes and markets drugs. The company is based in Titusville, NJ. The CEO of the company is Samuele Butera. | Health Technology |
- Bolsa de valores
- Insiders
- Jean-Marc Bellemin
- Experiencia